SEARCH

SEARCH BY CITATION

References

  • 1
    Jureidini JN. Epidemic of schizophrenia in children or inappropriate prescribing? [letter]. MJA 2000; 173: 5556.
  • 2
    Jensen P, Bhatara VS, Vitiello B, Hoagwood K, Feil M, Burke L. Psychoactive medication prescribing practices for US children: gaps between research and clinical practice. J. Am. Acad. Child Adolesc. Psychiatry 1999; 38: 55765.
  • 3
    Zito JM, Safer DJ, DosReis S, Gardner JF, Boles M, Lynch F. Trends in the prescribing of psychotropic medications to preschoolers. JAMA 2000; 283: 102530.
  • 4
    Rushton JL, Whitmire T. Pediatric stimulant and selective seretonin reuptake inhibitor prescription trends 1992−1998. Arch. Pediatr. Adolesc. Med. 2001; 155: 5605.
  • 5
    Rappley MD, Mullan PB, Alvarez FJ, Eneli IU, Wang J, Gardiner JC. Diagnosis of attention-deficit/hyperactivity disorder and use of psychotropic medication in very young children. Arch. Pediatr. Adolesc. Med. 1999; 153: 103945.
  • 6
    Salmelainen P. Trends in the Prescribing of Stimulant Medication for the Treatment of Attention Deficit Hyperactivity Disorder in Children and Adolescents in NSW. NSW Department of Health, Sydney, 2002.
  • 7
    Berbatis CG, Sunderland VB, Bulsara M. Licit psychostimulant consumption in Australia, 1984−2000: international and jurisdictional comparison. MJA 2002; 177: 53943.
  • 8
    Efron D, Hiscock H, Sewell J, Cranswick N, Vance A, Tyl Y, Luk E. The prescribing of psychotropic medications for children by Australian pediatricians and child psychiatrists. Pediatrics 2003; 111: 3725.
  • 9
    Shirkey H. Therapeutic orphans. J. Pediatr. 1968; 72: 11920.
  • 10
    Blumer JL. Off-label uses of drugs in children. Pediatrics 1999; 104: 598602.
  • 11
    King B, Zwi K, Nunn K, Longworth J, Dosseter D. Use of risperidone in a paediatric population: An observational study. J. Paediatr. Child Health 2003; 39: 5237.
  • 12
    Research Units on Pediatric Psychopharmacology Autism Network. Risperidone in children with autism and serious behavioural problems. NEJM 2002; 347: 31421.
  • 13
    The MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention deficit/hyperactivity disorder. Arch. Gen. Psychiatry 1999; 56: 107386.